Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugs-Reference-Cited by-同舟云学术

Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugs

Published:2013-11 Issue:17 Volume:49 Page:3708-3717
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tsubaki Masanobu,Komai Makiko,Itoh Tatsuki,Imano Motohiro,Sakamoto Kotaro,Shimaoka Hirotaka,Ogawa Naoki,Mashimo Kenji,Fujiwara Daichiro,Takeda Tomoya,Mukai Junji,Sakaguchi Katsuhiko,Satou Takao,Nishida Shozo

Funder

Japan Society for the Promotion of Science (JSPS)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Survival and proliferation factors of normal and malignant plasma cells;Klein;Int J Hematol,2003

2. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications;Hideshima;Oncogene,2001

3. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma;Kuku;Mediators Inflamm,2005

4. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications;Lauta;Cancer,2003

5. Response to thalidomide in multiple myeloma: impact of angiogenic factors;Rosiñol;Cytokine,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow inflammation in haematological malignancies;Nature Reviews Immunology;2024-03-15

2. Bleeding and Thrombosis in Multiple Myeloma: Platelets as Key Players during Cell Interactions and Potential Use as Drug Delivery Systems;International Journal of Molecular Sciences;2023-11-01

3. Molecular and immunological mechanisms of clonal evolution in multiple myeloma;Frontiers in Immunology;2023-09-06

4. A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments;Cancers;2022-08-04

5. PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells;Oncology Letters;2022-02-03